Cancer Targeted Technology LLC, based in Woodinville, WA, is a pioneering biotechnology company focused on developing innovative solutions for the diagnosis and treatment of cancer. Specializing in small molecular weight enzyme inhibitors, the company is at the forefront of creating cutting-edge imaging and drug delivery technologies.
With a strong emphasis on prostate cancer, Cancer Targeted Technology has successfully patented diagnostic PET imaging agent CTT1057 and radiotherapeutic drug CTT1403, both designed to revolutionize the way this type of cancer is diagnosed and treated. The company's groundbreaking research and development efforts have garnered significant recognition, including milestone payments and grants from prestigious institutions like the NIH.
Generated from the website